NightHawk Biosciences, Inc NHWK Stock Price Today, Quote & News

52 week high is the highest price of a stock in the past 52 weeks, or one year. NightHawk Biosciences Inc 52 week high is $3.42 as of April 28, 2023. One share of NHWK stock can currently be purchased for approximately $0.66.

It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. NEW YORK — Exco Resources Inc. on Thursday traded at a slight premium after pricing its initial public offering atop the planned range. A roundup of the latest corporate earnings reports and what companies are saying about future quarters. The company is scheduled to release its next quarterly earnings announcement on Monday, May 15th 2023. Join thousands of traders who make more informed decisions with our premium features.

Carol Massar and Tim Stenovec host a look back at the best interviews, discussions and more. Upgrade to MarketBeat All Access to add more stocks to your watchlist. NightHawk Biosciences trades on the New York Stock Exchange under the ticker symbol “NHWK.”

NightHawk Biosciences Announces Buildout of Advanced Biosafety Level 2 (BSL- Laboratory

To see all exchange delays and terms of use please see Barchart’s disclaimer. Real-time analyst ratings, insider transactions, earnings data, and more. The Company specializes in the end-to-end development, manufacturing, and commercialization of medical countermeasures that combat unmet and emerging biothreats. It provides process development and biomanufacturing services to support its biotherapeutics and discovery pipeline. The Company’s monoclonal antibody ANTHIM is a monoclonal antibody that binds the protective antigen component of… NightHawk Biosciences shares reverse split before market open on Friday, December 11th 2020.

A stock’s beta measures how closely tied its price movements have been to the performance of the overall market. Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated. There may be delays, omissions, or inaccuracies in the Information. The scores are based on the trading styles of Value, Growth, and Momentum. There’s also a VGM Score (‘V’ for Value, ‘G’ for Growth and ‘M’ for Momentum), which combines the weighted average of the individual style scores into one score.

We also https://1investing.in/ both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters. NightHawk Biosciences, Inc., an integrated biopharmaceutical company, develops, manufactures, and commercializes medical countermeasures that combat unmet and emerging biothreats. The company develops ANTHIM , a monoclonal antibody antitoxin for the treatment of inhalational anthrax. NightHawk Biosciences, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina. Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends.

How we make money

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research. Our Quantitative Research team models direct competitors or comparable companies from a bottom-up perspective to find companies describing their business in a similar fashion. The industry with the best average Zacks Rank would be considered the top industry , which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank would place in the bottom 1%. An industry with a larger percentage of Zacks Rank #1’s and #2’s will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4’s and #5’s.

• It provides process development and biomanufacturing services to support its biotherapeutics and discovery pipeline.
• The consensus among Wall Street analysts is that investors should “hold” NHWK shares.
• Bloomberg Businessweek Highlights from a week-long virtual event bringing Bloomberg Businessweek magazine to life.

These are established companies that reliably pay dividends. Money Flow Uptick/Downtick RatioMoney flow measures the relative buying and selling pressure on a stock, based on the value of trades made on an “uptick” in price and the value of trades made on a “downtick” in price. The up/down ratio is calculated by dividing the value of uptick trades by the value of downtick trades. Net money flow is the value of uptick trades minus the value of downtick trades.

NHWK NightHawk Biosciences, Inc.Stock Price & Overview

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank.

The company has a collaboration with Dr. James Shapiro at University of Alberta to manufacture surrogate mouse version of PTX-35. The company was formerly known as Heat Biologics, Inc. and changed its name to NightHawk Biosciences, Inc. in May 2022. NightHawk Biosciences, Inc. was incorporated in 2008 and is headquartered in Morrisville, North Carolina. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors.

Market Cap is calculated by multiplying the number of shares outstanding by the stock’s price. To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded.Dividend YieldA company’s dividend expressed as a percentage of its current stock price. NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company’s therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. The company develops HS-110, which has completed enrollment in a Phase II clinical trial to treat patients with advanced non-small cell lung cancer; and HS-130 that is in Phase I clinical trial for the treatment of advanced solid tumors.

NewsNightHawk Biosciences Inc.NHWK

The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. The Zacks Industry Rank assigns a rating to each of the 265 X Industries based on their average Zacks Rank. Sign Up NowGet this delivered to your inbox, and more info about our products and services. 52 week low is the lowest price of a stock in the past 52 weeks, or one year. NightHawk Biosciences Inc 52 week low is $0.66 as of April 28, 2023.

Intraday data delayed at least 15 minutes or per exchange requirements. High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks.

NEW YORK – Visicu on Tuesday increased the price of its initial public offering as Wall Street cast a favoring eye on one of the smaller deals on the calendar. CINCINNATI — Despite last week’s thin trading conditions, the U.S. markets weren’t lacking for technical developments. NightHawk Biosciences’ stock was trading at $0.8051 at the beginning of the year. Since then, NHWK stock has decreased by 18.0% and is now trading at $0.66.

Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations.

• To calculate, start with total shares outstanding and subtract the number of restricted shares.
• The technique has proven to be very useful for finding positive surprises.
• At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors.

Our calculations are based on comprehensive, delayed quotes. The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share .

Products

The 1-7 premarket stock trading was announced on Thursday, December 10th 2020. The number of shares owned by shareholders was adjusted after the market closes on Friday, December 11th 2020. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split. Represents the company’s profit divided by the outstanding shares of its common stock.

Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares.

In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies. Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. 1 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for NightHawk Biosciences in the last twelve months.

It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. NEW YORK — Chipotle Mexican Grill Inc., American Railcar Industries and NightHawk Radiology Services turned in the best year-to-date gains among the 32 initial public offerings so far as the first two months… NEW YORK — NightHawk Radiology CEO Dr. Paul Berger got a good clue of the coming success of his company’s initial public offering when he met with investors on his IPO road show.

The consensus among Wall Street analysts is that investors should “hold” NHWK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NHWK, but not buy additional shares or sell existing shares. Intraday Data provided by FACTSET and subject to terms of use. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only.